Nicofibrate is a fibrate-class lipid-lowering agent primarily used in the management of dyslipidemia to help reduce elevated levels of triglycerides and low-density lipoprotein cholesterol. By activating… Read more
Nicofibrate is a fibrate-class lipid-lowering agent primarily used in the management of dyslipidemia to help reduce elevated levels of triglycerides and low-density lipoprotein cholesterol. By activating peroxisome proliferator-activated receptors, this medication effectively modulates lipid metabolism. To ensure rigorous quality control and accurate analytical testing of this drug substance, laboratories rely on high-quality reference standards of the active pharmaceutical ingredient. This collection includes critical materials such as non-pharmacopeial impurities, drug metabolites, and stable isotope labelled compounds, which are essential for impurity profiling and method validation during pharmaceutical development. By utilizing these precise analytical tools, researchers and quality control professionals can effectively identify, quantify, and characterize potential degradants and metabolic products, thereby ensuring the safety, efficacy, and compliance of pharmaceutical formulations containing this lipid-modifying agent.